NewsSource: EClinCloud

AI-Driven, Shaping an Intelligent Future! EClinCloud's 5th Anniversary Annual Meeting Concludes Successfully

2 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: EClinCloud.

Article image
Article image
Article image
Article image

Five Years Together

Shaping an Intelligent Future

Highlights from EClinCloud's 5th Anniversary Annual Meeting

Article image
Article image

2025


Click the video to watch the highlights



Passion 2025

February 22: 5th Anniversary Celebration

EClinCloud Team Gathers in Chengdu

Team Synergy, Strategic Launch

Joyful Celebration, Writing a New Chapter Together



01

Climbing and Collaboration: Building Team Strength

Article image
Article image



Fun Icebreakers, Coordinated Teamwork

All-Out Sprint, Shared Victory

Article image
Article image
Article image
Article image
Article image
Article image

Strolling the Boardwalk, Reaching the Summit

Walking Side by Side, Sharing Laughter and Conversation

Article image
Article image
Article image
Article image



02

Starlight Gala Dinner, Witnessing Honor

Article image


Riding the AI Tailwind, Shaping an Intelligent Future

Founder & CEO Dr. Qin Long Takes the Stage to Speak

In 2025, EClinCloud Will

Ride the Tailwind of "AI"

Break Through the Waves of "Cost & Efficiency"

Usher in a Future of Comprehensive Intelligent Empowerment for New Drug Research and Development

Article image


Recognizing Excellence, Rewarding Hard Work

Moments of Honor, Cash Incentives

Red Envelope Rain, Endless Surprises

Generous Prizes, Electrifying Atmosphere

Article image


Company Executives Present Honorary Awards


Swipe left or right to view more

Article image
Article image
Article image


Creative Stage, Lighting Up the Venue

Energetic Teams, Showcasing Diverse Talents

Singing, Dancing, and Drama in Full Swing

Fun Interactions, Nonstop Joy

Swipe left or right to view more

Article image
Article image
Article image
Article image
Article image



A New Starting Point at 5 Years

Setting Sail Again, Driven by AI

2025: Looking Forward to Embarking on a New Journey with You!





About EClinCloud

EClinCloud is a technology company focused on clinical R&D, providing an integrated, interoperable all-in-one cloud platform for clinical trials (including solutions such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis within various technology products and solutions including eCOA, CTMS, eTMF, EDC, RTSM, and RM) as well as clinical trial endpoint assessment technologies across different therapeutic areas (including central nervous system, ophthalmology, and others). By combining cutting-edge technology with life data, EClinCloud is building a globally leading, patient-centric SaaS cloud platform supporting clinical evidence to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.







Article image

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.